CU20100174A7 - HETEROCYCLIC OR HIPERBYCLIC BICYCLIC DERIVATIVES LINKED PYRAZOL [1,5-A] PYRIMIDINES, PROCEDURE FOR PREPARATION AND USES OF THE SAME - Google Patents

HETEROCYCLIC OR HIPERBYCLIC BICYCLIC DERIVATIVES LINKED PYRAZOL [1,5-A] PYRIMIDINES, PROCEDURE FOR PREPARATION AND USES OF THE SAME

Info

Publication number
CU20100174A7
CU20100174A7 CU20100174A CU20100174A CU20100174A7 CU 20100174 A7 CU20100174 A7 CU 20100174A7 CU 20100174 A CU20100174 A CU 20100174A CU 20100174 A CU20100174 A CU 20100174A CU 20100174 A7 CU20100174 A7 CU 20100174A7
Authority
CU
Cuba
Prior art keywords
hiperbyclic
pyrimidines
pyrazol
heterocyclic
procedure
Prior art date
Application number
CU20100174A
Other languages
Spanish (es)
Inventor
Alejandro Lee Dunnick
Chunchun Zhang
Grandi Martin Joseph Di
Xiaolun Wang
Dan Maarten Berger
Minu Dhanjish Dutia
Nancy Torres
Darrin William Hopper
Jeremy Ian Levin
Original Assignee
Wyeth Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Llc filed Critical Wyeth Llc
Priority to CU20100174A priority Critical patent/CU20100174A7/en
Publication of CU20100174A7 publication Critical patent/CU20100174A7/en

Links

Landscapes

  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se describen compuestos de fórmula A: ESPACIO PARA LA FÓRMULA y sales farmacéuticamente aceptables de los mismos, que inhiben selectivamente la actividad Raf quinasa y son útiles para tratar trastornos mediados por Raf quinasas.Compounds of formula A are described: SPACE FOR FORMULA and pharmaceutically acceptable salts thereof, which selectively inhibit Raf kinase activity and are useful for treating disorders mediated by Raf kinases.

CU20100174A 2010-08-26 2010-08-26 HETEROCYCLIC OR HIPERBYCLIC BICYCLIC DERIVATIVES LINKED PYRAZOL [1,5-A] PYRIMIDINES, PROCEDURE FOR PREPARATION AND USES OF THE SAME CU20100174A7 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CU20100174A CU20100174A7 (en) 2010-08-26 2010-08-26 HETEROCYCLIC OR HIPERBYCLIC BICYCLIC DERIVATIVES LINKED PYRAZOL [1,5-A] PYRIMIDINES, PROCEDURE FOR PREPARATION AND USES OF THE SAME

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CU20100174A CU20100174A7 (en) 2010-08-26 2010-08-26 HETEROCYCLIC OR HIPERBYCLIC BICYCLIC DERIVATIVES LINKED PYRAZOL [1,5-A] PYRIMIDINES, PROCEDURE FOR PREPARATION AND USES OF THE SAME

Publications (1)

Publication Number Publication Date
CU20100174A7 true CU20100174A7 (en) 2011-10-31

Family

ID=45000128

Family Applications (1)

Application Number Title Priority Date Filing Date
CU20100174A CU20100174A7 (en) 2010-08-26 2010-08-26 HETEROCYCLIC OR HIPERBYCLIC BICYCLIC DERIVATIVES LINKED PYRAZOL [1,5-A] PYRIMIDINES, PROCEDURE FOR PREPARATION AND USES OF THE SAME

Country Status (1)

Country Link
CU (1) CU20100174A7 (en)

Similar Documents

Publication Publication Date Title
ECSP10010429A (en) HETEROCYCLIC OR HIPERBYCLIC BICYCLIC DERIVATIVES LINKED, PIRAZOLO [1,5-A] PYRIMIDINES, PROCEDURES FOR THEIR PREPARATION AND USES OF THE SAME
MX381849B (en) PYRAZOLO[1,5-a]PYRIMIDINE-BASED COMPOUNDS, COMPOSITIONS COMPRISING THEM, AND METHODS OF THEIR USE
LTPA2020504I1 (en) Substituted pyrazolo [1,5-a] pyrimidine compounds as Trk kinase inhibitors
MX382354B (en) HETEROCYCLIC COMPOUNDS AND THEIR USES.
ECSP088121A (en) PIRROLO DERIVATIVES [2,3-B] PYRIDINE AS PROTEIN KINASE INHIBITORS
MX388140B (en) SUBSTITUTED PYRAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS.
CO6620050A2 (en) Aminopyrimidine derivatives as modulators of lrrk2
BRPI0811617A2 (en) primidine derivatives and compositions as c-kit and pdgfr kinase inhibitors.
ECSP13012611A (en) PIRAZOL-AMINOPIRIMIDINE DERIVATIVES AS MODULATORS OF THE LRRK2
CL2014001529A1 (en) Substituted pyrazolo [1,5-a] pyridine compounds, inhibitors of the tropomyosin kinase receptor (trk); pharmaceutical composition that includes them; method of inhibiting the tropomyosin kinase receptor a (trka); and method of treatment or prevention of pain, cancer, restenosis and atherosclerosis, among other diseases.
PH12013501758A1 (en) Pyrazolo [1,5-a] pyridines as trk inhibitors
EA201000615A1 (en) IMIDAZO [1,2-A] PYRIDINE DERIVATIVES APPLICABLE AS APC INHIBITORS (ACTIVIN-like KINASE)
EA201100580A1 (en) IMIDAZOPIRIDAZINCARBONITRILE USED AS KINASE INHIBITORS
CU20140023A7 (en) DERIVATIVES OF N- (3- (1,2,4-OXADIAZOL-3/5-IL) PHENYL) IMIDAZO [1,2-a] PIRIDIN-3-CARBOXAMIDE AS INHIBITORS OF KINASE C-Kit
DK3808749T3 (en) PYRAZOLO[1,5-A]PYRIMIDINES USEFUL AS ATR KINASE INHIBITORS FOR THE TREATMENT OF CANCER
BR112014028395A2 (en) substituted 3,4-dihydro-2h-pyrido [1,2-a] pyrazine-1,6-dione derivatives useful for the treatment of (inter alia) alzheimer's disease
CR20140288A (en) BENZOTIENILO-PIRROLOTRIAZINAS DISUSTITUIDAS AND ITS USES
MX347917B (en) Imidazo [1, 2 - b] pyridazine - based compounds, compositions comprising them, and uses thereof.
ECSP10010263A (en) 4-PIRAZOLIL-N-ARILPIRIMIDIN-2-AMINAS AND 4-PIRAZOLIL-N-HETEROARILPIRIMIDIN-2-AMINAS AS INHIBITORS OF JANUS KINASES
PH12013502020A1 (en) Pyrrolo [2,3-d] pyrimidine derivatives as inhibitors of tropomyosin-related kinases
MX2009010728A (en) Imidazo[1,2-a]pyridine compounds as receptor tyrosine kinase inhibitors.
CL2011001947A1 (en) Compounds derived from substituted phenyl- {1,2,4} triazolo [1,5-a] pyridine-phenylamino, kinase inhibitors; Useful for treating disorders associated with vascular permeability.
AR080871A1 (en) I HAVE [3,2-B] REPLACED PYRIDINS AS INHIBITORS OF THE ACTIVITY OF PROTEIN THYROSINE KINASE
UY32046A (en) DERIVATIVES OF 2-ALQUIL-6-CICLOAMINO-3- (PIRIDIN-4-IL) IMIDAZOZ [1,2-B] -PIRIDAZINA, ITS PREPARATION AND ITS APPLICATION IN THERAPEUTICS
DK3083627T3 (en) [1,2,4] TRIAZOL [1,5-A] PYRIMIDINE DERIVATIVES AS PROTOZOIC PROTEASOMIN INHIBITORS FOR THE TREATMENT OF PARASITIC DISEASES, SUCH AS LEISHMANIASIS